Additional manufacturer narrative: review of the manufacturing records could not be performed as no lot number information was provided.The devices were not returned.Consequently, direct product analysis was not possible.Additional information about these events could not be obtained.As a result, no further investigation is possible.All information has been placed on file for use in tracking and trending.Note: no actual event date was provided.Therefore, date of event is an estimate based on publication date of the article.Note: no actual patient age was provided.Therefore, age at time of event is an estimate based on the average age identified in the article.(b)(4).
|
The following information was obtained through literature review: t, abe., et al (may, 2018)."treatment results using gore® acuseal vascular graft." the japanese journal of phlebology.29 (2).261.From april, 2016 to january, 2018, 32 patients underwent arterio-venous shunt procedures using gore® acuseal vascular grafts to treat renal disease.Patient demographics shows that there were 20 males and 12 females with the average age of 66.3 years old.25 patients were implanted with the gore® acuseal vascular graft in their forearms, 7 patients were in their upper arms, and loop shunt was created among 24 patients while straight-shaped shunt was among 8 patients.Treatment results show 2 patients suffered from graft infection due to dialysis puncture in case #1, case #2, infection was due to dehiscence at the graft anastomosis site.In case #1, the gore® acuseal vascular graft was totally replaced with another vascular graft while in case #2, the gore® acuseal vascular graft was partially removed to treat graft infection.
|